CXCR1 and neoplasm: Our data suggest that specific inhibition of CXCR1 may be a potential target of interest in glioblastoma and other tumor types that are characterized by high levels of neutrophil infiltration or alternatively as a potential prophylactic measure for patients at high risk of developing inflammation-associated cancers.